S. Goldenberg

J. Otter, E. Dyakova, O. Auguet, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.

D. Shawcross, S. Goldenberg, L. Edwards, 2021, Gastroenterology.

Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonization with extended spectrum β-lactamase Enterobacteriaceae.

J. Otter, E. Dyakova, J. Edgeworth, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.

J. Otter, E. Dyakova, J. Edgeworth, 2016, The Journal of antimicrobial chemotherapy.

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)—A Case Report

P. Irving, B. Merrick, P. Yong, 2022, Infectious disease reports.

Use of online pharmacies to obtain antimicrobials without valid prescription.

S. Goldenberg, 2011, QJM : monthly journal of the Association of Physicians.

Identification of critical coronary artery disease

S. Goldenberg, 2011 .

Multiplex molecular testing for management of infectious gastroenteritis in a hospital setting: a comparative diagnostic and clinical utility study.

J. Edgeworth, K. Bisnauthsing, E. Aarons, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.

G. French, S. Smith, S. Goldenberg, 2010, The Journal of hospital infection.

Point-of-Care Testing for Clostridium Difficile Infection: A Real-World Feasibility Study of a Rapid Molecular Test in Two Hospital Settings

R. Schiff, K. Bisnauthsing, Amita Patel, 2014, Infectious Disease and Therapy.

Rapid detection of sequence variation in Clostridium difficile genes using LATE-PCR with multiple mismatch-tolerant hybridization probes.

K. Pierce, L. Wangh, G. French, 2012, Journal of microbiological methods.

Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.

G. French, S. Goldenberg, 2011, The Journal of infection.

Detection of toxigenic Clostridium difficile in diarrheal stools by rapid real-time polymerase chain reaction.

G. French, S. Goldenberg, T. Dieringer, 2010, Diagnostic microbiology and infectious disease.

Opportunistic fungal lung infections

S. Goldenberg, N. Price, 2008 .

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

E. Bouza, M. Vehreschild, F. Thalhammer, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Existing and investigational therapies for the treatment of Clostridium difficile infection: A focus on narrow spectrum, microbiota-sparing agents.

S. Goldenberg, H. Maxwell-Scott, 2017, Medecine et maladies infectieuses.

Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards.

S. Tsoka, P. Royall, A. Mason, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in London

J. Otter, J. Edgeworth, J. Hughes, 2016, Journal of infection prevention.

A solution to the problem of antibiotic induced collateral damage to the gut microbiome.

S. Goldenberg, 2019, The Lancet. Infectious diseases.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

N. Bhala, A. Hart, D. Moore, 2018, The Journal of hospital infection.

A cost benefit analysis of the Luminex xTAG Gastrointestinal Pathogen Panel for detection of infectious gastroenteritis in hospitalised patients.

J. Edgeworth, K. Bisnauthsing, P. Brazier, 2015, The Journal of infection.

Performance evaluation of the Verigene® (Nanosphere) and FilmArray® (BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections

P. Wade, S. Goldenberg, K. Stocker, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Molecular-based diagnostics, including future trends

S. Goldenberg, 2013, Medicine.

Molecular-based diagnostics, including future trends

S. Goldenberg, 2013, Medicine.

Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection.

J. A. Salkeld, J. Otter, P. Stoodley, 2015, The Journal of hospital infection.

Performance evaluation of the Verigene® (Nanosphere) and FilmArray® (BioFire®) molecular assays for identification of causative organisms in bacterial bloodstream infections

P. Wade, S. Goldenberg, K. Stocker, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Regulation, risk and safety of Faecal Microbiota Transplant

D. Shawcross, B. Merrick, Benjamin Forbes, 2020, Infection Prevention in Practice.

Performance of the GeneXpert CT/NG Assay Compared to That of the Aptima AC2 Assay for Detection of Rectal Chlamydia trachomatis and Neisseria gonorrhoeae by Use of Residual Aptima Samples

S. Goldenberg, J. Finn, C. Tong, 2012, Journal of Clinical Microbiology.

The management of osteomyelitis in hidradenitis suppurativa.

N. Griffin, F. Ferguson, E. Rashidghamat, 2023, International journal of dermatology.

Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination☆

D. J. Weber, David J Weber, C. Donskey, 2015, Journal of Hospital Infection.

Myopericarditis Associated With Campylobacter jejuni Gastroenteritis: A Case Report

S. Goldenberg, N. Price, J. Coutts, 2010 .

Public Reporting of Clostridium difficile and Improvements in Diagnostic Tests

S. Goldenberg, 2011, Infection Control & Hospital Epidemiology.

Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line.

V. Anttila, H. Seifert, C. Wenisch, 2015, The Journal of hospital infection.

N. Bhala, A. Hart, D. Moore, 2018, Gut.

Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review

I. Beales, A. Narbad, J. Digby-Bell, 2018, Infectious Diseases and Therapy.

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?

G. Ianiro, J. Marchesi, B. Mullish, 2020, Clinical Immunology.

Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England.

G. French, S. Goldenberg, 2011, The Journal of hospital infection.

Mandatory reporting and improvements in diagnosing Clostridium difficile infection: an incompatible dichotomy?

G. French, D. Tucker, P. Wade, 2011, The Journal of infection.

The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations

D. Nayar, T. Planche, P. Howard, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction.

G. French, S. Goldenberg, A. Patel, 2011, Diagnostic microbiology and infectious disease.

Glutamate Dehydrogenase for Laboratory Diagnosis of Clostridium difficile Infection

G. French, S. Goldenberg, P. Cliff, 2010, Journal of Clinical Microbiology.

Laboratory Diagnosis of Clostridium difficile Infection

G. French, S. Goldenberg, P. Cliff, 2010, Journal of Clinical Microbiology.

Faecal microbiota transplantation for refractory Clostridiumdifficile infection

P. Irving, S. Goldenberg, Christopher Is Meadows, 2019, BMJ Case Reports.

Effectiveness of early use of fidaxomicin in preventing recurrence of Clostridium difficile infection.

N. Wigglesworth, P. Wade, S. Goldenberg, 2019, The Journal of hospital infection.

E. Bouza, M. Vehreschild, F. Thalhammer, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes

S. Goldenberg, R. Tresman, 2018, The Journal of antimicrobial chemotherapy.

Expanding the armamentarium for the treatment of Clostridium difficile infection.

S. Goldenberg, 2017, Lancet. Infectious Diseases (Print).

Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation.

S. Goldenberg, 2016, The Journal of hospital infection.

De-isolation of COVID-19–positive hemodialysis patients in the outpatient setting: a single-center experience

C. Hemsley, S. Goldenberg, C. Dudreuilh, 2020, Kidney International.

Contamination of the Hospital Environment From Potential Clostridium difficile Excretors Without Active Infection

J. Otter, J. Biswas, E. van Kleef, 2015, Infection Control & Hospital Epidemiology.

Healthcare resource use in hospitalised patients with carbapenem resistant Gram-negative infections.

K. Bisnauthsing, B. Merrick, S. Goldenberg, 2021, The Journal of hospital infection.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.

V. Anttila, B. Guery, M. Vehreschild, 2017, The Lancet. Infectious diseases.

Clinical negligence, litigation and healthcare-associated infections.

G. French, S. Goldenberg, H. Volpé, 2012, The Journal of hospital infection.

Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.

J. Otter, J. Biswas, E. van Kleef, 2015, The Journal of hospital infection.

Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer: A reply.

S. Goldenberg, S. Wilmore, 2018, The Journal of infection.

Laboratory diagnosis of Clostridium difficile.

S. Goldenberg, 2013, The Lancet. Infectious diseases.

The diagnosis of C. difficile infection (CDI) – Two steps forwards?

G. French, D. Tucker, P. Wade, 2011 .

Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK

K. Turner, J. Macleod, Robin K. Meray, 2014, BMJ Open.

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

K. Turner, J. Macleod, A. Deol, 2013, Sexually Transmitted Infections.

P2.012 Clinical Care Pathways Using Chlamydia and Gonorrhoea Tests Are Evolving: Point of Care Nucleic Acid Amplification Tests May Reduce Genitourinary Medicine Service Delivery Costs

J. Macleod, E. Adams, K. Turner, 2013, Sexually Transmitted Infections.

Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward☆

R. Glover, E. Adams, A. Vecino-Ortiz, 2018, Diagnostic Microbiology and Infectious Disease.

The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey

A. Gasbarrini, S. Vermeire, K. Garborg, 2021, The Lancet regional health. Europe.

Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial

J. Bell, M. Shankar-Hari, C. Bunce, 2020, BMJ Open.

Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model

J. Otter, N. Hawkins, M. Lumley, 2020, PharmacoEconomics.

A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

H. Tilg, F. Mégraud, A. Gasbarrini, 2020, United European gastroenterology journal.

Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug

A. Gasbarrini, C. Mulder, E. Kuijper, 2019, United European gastroenterology journal.

A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations.

A. Gasbarrini, E. Kuijper, J. Keller, 2019, The Lancet. Infectious diseases.

Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK)

G. Barlow, B. Parcell, D. Manissero, 2022, Advances in Therapy.

Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)

D. Shawcross, D. Moyes, B. Merrick, 2023, Infectious disease reports.

Introduction to the joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) faecal microbiota transplant guidelines.

H. Williams, J. Segal, B. Mullish, 2018, Journal of Hospital Infection.

The Enigma ML FluAB-RSV assay: a fully automated molecular test for the rapid detection of influenza A, B and respiratory syncytial viruses in respiratory specimens

J. Edgeworth, S. Goldenberg, 2015, Expert review of molecular diagnostics.

A parallel diagnostic accuracy study of three molecular panels for the detection of bacterial gastroenteritis

J. Biswas, S. Goldenberg, A. Al-Ali, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing

T. Peto, D. Crook, A. Walker, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.

M. Jit, W. Edmunds, B. Cookson, 2016, Vaccine.

Successful faecal microbiota transplant for recurrent Clostridium difficile infection delivered by colonoscopy through a diverted ileostomy in a patient with severe perianal Crohn’s disease

J. Digby-Bell, P. Irving, S. Goldenberg, 2018, BMJ Case Reports.

Routine respiratory metagenomics service for intensive care unit patients

D. Jeyaratnam, J. Edgeworth, C. Hemsley, 2023, medRxiv.

Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR)

T. Spector, C. Steves, C. Stanley, 2020, BMC Infectious Diseases.

Hidden burden of undiagnosed Clostridium difficile infection.

S. Goldenberg, 2014, The Lancet. Infectious diseases.

The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations

D. Jenkins, D. Nayar, T. Planche, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Molecular detection of common intestinal parasites: a performance evaluation of the BD Max™ Enteric Parasite Panel

R. Batra, W. Newsholme, S. Goldenberg, 2016, European Journal of Clinical Microbiology & Infectious Diseases.

Paraspinal tuberculosis

S. Goldenberg, N. Price, 2006, Medical Journal of Australia.

The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study

S. Neil, J. Edgeworth, R. Batra, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line.

V. Anttila, C. Wenisch, D. Jenkins, 2015, The Journal of hospital infection.

Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach.

M. Jit, W. Edmunds, B. Cookson, 2014, The Journal of hospital infection.

Performance of the GeneXpert CT/NG Assay Compared to That of the Aptima AC2 Assay for Detection of Rectal Chlamydia trachomatis and Neisseria gonorrhoeae by Use of Residual Aptima Samples

S. Goldenberg, J. Finn, C. Tong, 2012, Journal of Clinical Microbiology.

Expanding the armamentarium for the treatment of Clostridium difficile infection.

S. Goldenberg, 2017, The Lancet. Infectious diseases.

Contamination of the Hospital Environment From Potential Clostridium difficile Excretors Without Active Infection

J. Otter, J. Biswas, E. van Kleef, 2015, Infection Control & Hospital Epidemiology.

Optical density cut-off values for Clostridium difficile enzyme immunoassays.

G. French, S. Goldenberg, E. Simpson, 2011, Journal of Hospital Infection.

Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination

David J Weber, C. Donskey, J. Otter, 2015, Journal of Hospital Infection.

Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom

M. Gheorghe, J. Gordon, S. Goldenberg, 2023, PharmacoEconomics.